CIITA and cancer: Representative examples of MHC-I and MHC-II players in liver cancer, such as B2M and CIITA, showed similar patterns as other cancer types, with heterogenous protein expression in tissue microarrays (Fig. 8a, c) and low gene expression being predictive of poor survival (Fig. 8b, d).